Últimas noticias sobre BioLine Rx (NASDAQ:BLRX) Bolsa

BioLine Rx

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEON

ANIP

BBAI

BLRX

CFFI

DOYU

GCTK

LUXH

PMAX

QUBT

RIME

SANG

SIBN

SLXN

SOBR

SONM

TNXP

WHLR

TSMC y otras acciones destacaron en el premercado tras reportar ganancias récord. Descubre los mayores ganadores y perdedores.

Acciones de Taiwan Semiconductor (TSM) suben alrededor del 5%; 20 acciones en movimiento en el premercado de EE.UU.

Equities

Eurozone

Commodities

Intraday Update

BHAT

FUBO

SPRC

Los mercados financieros avanzan con el Dow Jones subiendo 200 puntos. Conoce las acciones ganadoras, caídas y tendencias en materias primas.

Índices bursátiles al alza: Las acciones tecnológicas impulsan a Wall Street este lunes

ARKR

AURA

CHEK

CMCT

COEP

IDAI

LINC

MGOL

NINE

RSVR

Conoce las acciones que lideran el premercado tras movimientos clave: Check-Cap sube un 52,2% gracias a nueva patente.

Las acciones de Check-Cap suben un 52%; 20 acciones que se están moviendo antes de la apertura del mercado

BioLineRx Ltd. - American Depositary Shares

BioLine Rx Ltd

<a href="https://patentcenter.uspto.gov/applications/18270521/ifw/docs">https://patentcenter.uspto.gov/applications/18270521/ifw/docs</a>
<figure class="image"><img src="https://pbs.twimg.com/media/GijdKA7bIAAfCgm?format=jpg&amp;name=small" alt="Image" /></figure><figure class="image"><img src="https://pbs.twimg.com/media/GijdKA8bwAAhU72?format=jpg&amp;name=small" alt="Image" /></figure><figure class="image"><img src="https://pbs.twimg.com/media/GijdKA8bUAE26DK?format=jpg&amp;name=900x900" alt="Image" /></figure>

Biotech

General

BioLineRx Ltd Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITION OF BL-8040 (FOR THE TREATMENT OF CANCER)"

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Guidance

Management

BioLineRx Outlines Vision For 2025: Plans New Oncology/Rare Disease In-Licensing, 1-For-40 Reverse Stock Split To Meet Nasdaq Compliance, $29.5M Cash, Runway Through H2 2026

<h3>Gainers</h3>
<ul>
<li>AnaptysBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANAB#NASDAQ">ANAB</a>) shares moved upwards by 29.7% to $19.5 during Friday's pre-market session. The market value of their outstanding shares is at $593.3 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock rose 25.88% to $0.09. The company's market cap stands at $1.4 million. </li>
<li>Channel Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) stock increased by 18.74% to $1.14. The company's market cap stands at $6.8 million. </li>
<li>Immuron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRN#NASDAQ">IMRN</a>) stock moved upwards by 18.65% to $2.35. The company's market cap stands at $13.3 million. </li>
<li>Moleculin Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) stock increased by 14.36% to $1.99. The company's market cap stands at $6.3 million. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) shares rose 13.66% to $1.83. The market value of their outstanding shares is at $21.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) shares fell 21.6% to $0.1 during Friday's pre-market session. The market value of their outstanding shares is at $12.7 million. </li>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) stock declined by 17.78% to $0.31. The market value of their outstanding shares is at $1.5 million. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) shares declined by 12.29% to $0.15. The market value of their outstanding shares is at $11.9 million. </li>
<li>PureTech Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTC#NASDAQ">PRTC</a>) shares decreased by 7.69% to $16.7. The market value of their outstanding shares is at $399.8 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock fell 7.17% to $3.11. The company's market cap stands at $2.1 million. </li>
<li>QT Imaging Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTI#NASDAQ">QTI</a>) shares declined by 6.88% to $0.49. The company's market cap stands at $10.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANAB

CHRO

IMRN

MBRX

PRTC

RNAZ

SCPX

12 Health Care Stocks Moving In Friday's Pre-Market Session

U.S. stocks traded higher toward the end of trading, with the S&amp;P 500 gaining around 1% on Friday.
The Dow traded up 0.99% to 43,580.17 while the NASDAQ rose 1.81% to 19,688.08. The S&amp;P 500 also rose, gaining, 1.25% to 6,011.81.
Check This Out: <a href="https://www.benzinga.com/25/01/43051869/top-3-defensive-stocks-that-could-blast-off-this-quarter">Top 3 Defensive Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Consumer discretionary shares surged by 2.3% on Friday.
In trading on Friday, health care shares fell by 0.1%.
Top Headline
State Street Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) posted better-than-expected fourth-quarter earnings on Friday.
The company reported fourth quarter adjusted earnings per share of $2.60, beating the street view of $2.43. Quarterly sales of $3.412 billion (+12%) outpaced the analyst consensus estimate of $3.320 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) shares shot up 54% to $31.57 after the company announced it resolved its Nasdaq delisting notice and is now achieving compliance with the listing standards.</li>
<li>Shares of Versus Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>)got a boost, surging 42% to $2.73 after the company announced expansion into the Brazilian market as part of its strategy to grow its international footprint.</li>
<li>Qorvo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) shares were also up, gaining 14% to $83.60 following a WSJ report indicating activist investor Starboard Value has acquired a 7.7% stake in the company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Scorpius Holdings, Inc. &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NYSE">SCPX</a>) shares dropped 20% to $0.30 after the company announced its board approved a 1-for-20 reverse stock split.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 19% to $0.098 after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.</li>
<li>J B Hunt Transport Services Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) was down, falling 7% to $174.30 after the company reported fourth-quarter EPS below estimates.</li>
</ul>
Commodities In commodity news, oil traded down 0.6% to $78.23 while gold traded down 0.1% at $2,749.20.
Silver traded down 1.8% to $31.145 on Friday, while copper fell 1.8% to $4.3635.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 surged 0.69%, Germany's DAX 40 gained 1.20% and France's CAC 40 gained 0.98%. Spain's IBEX 35 Index rose 0.64%, while London's FTSE 100 gained 1.35%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 falling 0.31%, China's Shanghai Composite Index gaining 0.18%, Hong Kong's Hang Seng Index climbing 0.31% and India's BSE Sensex falling 0.55%.
Economics
<ul>
<li>U.S. industrial production rose by 0.9% in December, topping market estimates of a 0.3% increase.</li>
<li>Housing starts rose by 15.8% from the previous month to an annualized rate of 1.499 million units in December.</li>
<li>Building permits declined by 0.7% to an annualized rate of 1.483 million in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43055377/how-to-earn-500-a-month-from-3m-stock-ahead-of-q4-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q4 Earnings</a></li>
</ul>

Earnings

JBHT

NUKK

QRVO

Nasdaq Surges Over 300 Points; State Street Earnings Top Views

U.S. stocks traded higher midway through trading, with the S&amp;P 500 gaining around 1% on Friday.
The Dow traded up 0.86% to 43,524.83 while the NASDAQ rose 1.46% to 19,620.72. The S&amp;P 500 also rose, gaining, 1% to 5,996.98.
Check This Out: <a href="https://www.benzinga.com/25/01/43051869/top-3-defensive-stocks-that-could-blast-off-this-quarter">Top 3 Defensive Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Information technology shares surged by 1.8% on Friday.
In trading on Friday, health care shares rose by just 0.1%.
Top Headline
Fastenal Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) reported weaker-than-expected fourth-quarter earnings.
Fastenal reported sales growth of 3.7% year-over-year to $1.825 billion, missing the consensus of $1.844 billion. The company's fourth-quarter EPS was 46 cents, missing the estimate of 48 cents.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) shares shot up 62% to $33.26 after the company announced it resolved its Nasdaq delisting notice and is now achieving compliance with the listing standards.</li>
<li>Shares of Versus Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>)got a boost, surging 49% to $2.86 after the company announced expansion into the Brazilian market as part of its strategy to grow its international footprint.</li>
<li>Qorvo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) shares were also up, gaining 13% to $83.31 following a WSJ report indicating activist investor Starboard Value has acquired a 7.7% stake in the company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Scorpius Holdings, Inc. &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NYSE">SCPX</a>) shares dropped 27% to $0.27 after the company announced its board approved a 1-for-20 reverse stock split.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 21% to $0.096 after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.</li>
<li>J B Hunt Transport Services Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) was down, falling 7% to $173.60 after the company reported fourth-quarter EPS below estimates.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $78.28 while gold traded down 0.1% at $2,748.00.
Silver traded down 1.8% to $31.160 on Friday, while copper fell 1.4% to $4.3780.
Euro zone
European shares were higher today. The eurozone's STOXX 600 surged 0.74%, Germany's DAX 40 gained 1.15% and France's CAC 40 gained 1.06%. Spain's IBEX 35 Index rose 0.50%, while London's FTSE 100 gained 1.58%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 falling 0.31%, China's Shanghai Composite Index gaining 0.18%, Hong Kong's Hang Seng Index climbing 0.31% and India's BSE Sensex falling 0.55%.
Economics
<ul>
<li>U.S. industrial production rose by 0.9% in December, topping market estimates of a 0.3% increase.</li>
<li>Housing starts rose by 15.8% from the previous month to an annualized rate of 1.499 million units in December.</li>
<li>Building permits declined by 0.7% to an annualized rate of 1.483 million in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43055377/how-to-earn-500-a-month-from-3m-stock-ahead-of-q4-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q4 Earnings</a></li>
</ul>

FAST

S&P 500 Gains 1%; Fastenal Posts Downbeat Earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 300 points on Friday.
Following the market opening Friday, the Dow traded up 0.76% to 43,482.39 while the NASDAQ rose 1.36% to 19,601.89. The S&amp;P 500 also rose, gaining, 0.88% to 5,989.58.
Check This Out: <a href="https://www.benzinga.com/25/01/43051869/top-3-defensive-stocks-that-could-blast-off-this-quarter">Top 3 Defensive Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Consumer discretionary shares surged by 1.4% on Friday.
In trading on Friday, utilities shares fell by 0.1%.
Top Headline
U.S. industrial production rose by 0.9% in December, topping market estimates of a 0.3% increase.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) shares shot up 80% to $36.99 after the company announced it resolved its Nasdaq delisting notice and is now achieving compliance with the listing standards.</li>
<li>Shares of Versus Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>)got a boost, surging 45% to $2.8792 after the company announced expansion into the Brazilian market as part of its strategy to grow its international footprint.</li>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) shares were also up, gaining 43% to $0.3058.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Scorpius Holdings, Inc. &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NYSE">SCPX</a>) shares dropped 26% to $0.2783 after the company announced its board approved a 1-for-20 reverse stock split.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 25% to $0.0915 after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.</li>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) was down, falling 17% to $0.1419.</li>
</ul>
Commodities In commodity news, oil traded down 0.1% to $78.59 while gold traded down 0.2% at $2,745.00.
Silver traded down 1.7% to $31.185 on Friday, while copper fell 1.3% to $4.3825.
Euro zone
European shares were higher today. The eurozone's STOXX 600 surged 0.8%, Germany's DAX 40 gained 1.2% and France's CAC 40 gained 1.2%. Spain's IBEX 35 Index rose 0.7%, while London's FTSE 100 gained 1.5%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 falling 0.31%, China's Shanghai Composite Index gaining 0.18%, Hong Kong's Hang Seng Index climbing 0.31% and India's BSE Sensex falling 0.55%.
Economics
<ul>
<li>U.S. industrial production rose by 0.9% in December, topping market estimates of a 0.3% increase.</li>
<li>Housing starts rose by 15.8% from the previous month to an annualized rate of 1.499 million units in December.</li>
<li>Building permits declined by 0.7% to an annualized rate of 1.483 million in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43055377/how-to-earn-500-a-month-from-3m-stock-ahead-of-q4-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q4 Earnings</a></li>
</ul>

Dow Jumps Over 300 Points; US Industrial Production Beats Estimates

WIIM

BioLineRx shares are trading lower after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.

The change in exchange ratio for the ADSs will have the same effect as a 1-for-40 reverse stock split of the ADSs, reducing the number of outstanding ADSs from 142,340,133 to 3,558,503 ADSs.&nbsp;

BioLineRx Reports Change To Ratio Of American Depositary Shares To Ordinary Shares; Change In Exchange Ratio To Have Same Effect As 1-For-40 Reverse Stock Split

Shares of Taiwan Semiconductor Manufacturing Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) rose sharply in today's pre-market trading after the company announced <a href="https://www.benzinga.com/quote/TSM">fourth-quarter results</a>.
Taiwan Semiconductor Mfg. said net profit climbed 57% year-over-year to a record T$374.68 billion ($11.38 billion).
TSMC shares gained 4.7% to $216.61 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) gained 83.1% to $1.63 in pre-market trading after gaining 8% on Wednesday.</li>
<li>Powell Max Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) gained 67.8% to $2.45 in pre-market trading after the company announced acquisition plans and is targeting firms with between $1 million and $5 million in revenue to expand into the Hong Kong and Asian financial communications market.</li>
<li>BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) rose 40.1% to $0.1458 in pre-market trading after dipping 15% on Wednesday. BioLineRx recently announced a $10 million registered direct offering.</li>
<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) gained 39.3% to $3.28 in pre-market trading after falling 4% on Wednesday.</li>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) rose 22.5% to $0.1342 in pre-market trading after dipping 14% on Wednesday. AEON Biopharma recently announced closing of $20.0 million underwritten public offering</li>
<li>DouYu International Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) rose 17.4% to $14.43 in pre-market trading after the company named Ms. Simin Ren as co-CEO and announced a special cash dividend of $9.94/ADS.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) gained 15.1% to $3.90 in pre-market trading after the company announced a chief executive transition. BigBear.ai has appointed Kevin McAleenan as CEO and a member of the company's board, effective as of Wednesday. McAleenan will replace Mandy Long, who is transitioning to an advisory role.</li>
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) gained 12.8% to $0.2620 in pre-market trading.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) gained 10.3% to $12.74 in pre-market trading after surging 55% on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Transcontinental Realty Investors, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCI#NYSE">TCI</a>) shares fell 31.8% to $19.01 in pre-market trading.</li>
<li>Algorhythm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) fell 20.3% to $0.04 in pre-market trading after dipping 35% on Wednesday.</li>
<li>GlucoTrack, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) dipped 20.3% to $0.0630 in pre-market trading following a 35% decline on Wednesday.</li>
<li>Sonim Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) declined 15.5% to $3.19 in pre-market trading. Sonim Technologies shares gained 10% on Wednesday after Orbic North America announced an agreement in principle to acquire a substantial equity ownership position in the company.</li>
<li>C&amp;F Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFFI#NASDAQ">CFFI</a>) shares fell 15.3% to $60.01 in pre-market trading.</li>
<li>SI-BONE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) fell 14.7% to $14.01 in pre-market trading after gaining 5% on Wednesday. SI-BONE recently reported preliminary fourth-quarter revenue results.</li>
<li>LuxUrban Hotels Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) shares dipped 12.9% to $0.5991 in pre-market trading. LuxUrban Hotels recently issued FY25 revenue guidance.</li>
<li>Sangoma Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANG#NASDAQ">SANG</a>) fell 12.1% to $6.19 in today's pre-market trading after gaining 5% on Wednesday.</li>
<li>ANI Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIP#NASDAQ">ANIP</a>) shares tumbled 11.6% to $50.01 in pre-market trading. ANI Pharmaceuticals recently issued preliminary fourth quarter and 2024 financial results and preliminary 2025 outlook.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) fell 11.3% to $1.38 in pre-market trading after the company announced the pricing of $5.0 million public offering.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42998360/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>

Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Regional Health Props (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RHE#AMEX">RHE</a>) stock increased by 183.9% to $4.4 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million. </li>
<li>Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) shares moved upwards by 38.32% to $1.01. The market value of their outstanding shares is at $22.2 million. </li>
<li>Microbot Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBOT#NASDAQ">MBOT</a>) shares increased by 29.9% to $2.78. The market value of their outstanding shares is at $47.0 million. </li>
<li>Renovaro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENB#NASDAQ">RENB</a>) stock moved upwards by 23.11% to $1.14. The company's market cap stands at $180.9 million. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) shares moved upwards by 21.38% to $2.1. The market value of their outstanding shares is at $24.1 million. </li>
<li>CNS Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) shares rose 18.86% to $0.15. The market value of their outstanding shares is at $8.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) stock declined by 71.6% to $0.16 during Monday's pre-market session. The market value of their outstanding shares is at $6.4 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock fell 37.41% to $0.18. The market value of their outstanding shares is at $2.9 million. </li>
<li>BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) stock fell 29.0% to $0.19. The market value of their outstanding shares is at $16.3 million. </li>
<li>Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) stock fell 24.13% to $0.23. The company's market cap stands at $2.3 million. </li>
<li>Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) shares fell 18.31% to $1.45. The company's market cap stands at $8.9 million. </li>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) stock decreased by 17.93% to $0.45. The market value of their outstanding shares is at $2.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACON

AYTU

CNSP

EKSO

MBOT

RENB

12 Health Care Stocks Moving In Monday's Pre-Market Session

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping more than 200 points on Monday.
The Dow traded up 0.08% to 42,765.84 while the NASDAQ gained 1.05% to 19,828.63. The S&amp;P 500 also rose, gaining, 0.59% to 5,976.38.
Check This Out: <a href="https://www.benzinga.com/25/01/42810054/this-analyst-with-85-accuracy-rate-sees-around-16-downside-in-tesla-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts">This Analyst With 85% Accuracy Rate Sees Around 16% Downside In Tesla &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Information technology shares jumped by 2.1% on Monday.
In trading on Monday, utilities shares fell by 0.6%.
Top Headline
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) shares shot up 131% to $3.5824. Regional Health announced plans to merge with SunLink in a $10 million preferred stock deal.</li>
<li>Shares of SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>)got a boost, surging 108% to $1.10 after announcing the publication of a European patent application for binge behavior.</li>
<li>fuboTV Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NASDAQ">FUBO</a>) shares were also up, gaining 235% to $4.83 after the company announced it entered into a definitive agreement for Disney to combine its Hulu with Fubo to form a virtual MVPD company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) shares dropped 67% to $0.1884 after the company announced the pricing of approximately $20.0 million underwritten public offering.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 42% to $0.1586 after the company reported a $10 million registered direct offering.</li>
<li>Blue Hat Interactive Entertainment Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>) was down, falling 41% to $0.0868 after the company reported the pricing of $4.4 million registered direct offering.</li>
</ul>
Commodities In commodity news, oil traded down 0.1% to $73.92 while gold traded down 0.2% at $2,648.90.
Silver traded up 1.9% to $30.640 on Monday, while copper rose 2.4% to $4.1695.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.95%, Germany's DAX 40 gained 1.56% and France's CAC 40 climbed 2.24%. Spain's IBEX 35 Index rose 1.34%, while London's FTSE 100 rose 0.31%.
Asia Pacific Markets
Asian markets closed lower on Monday, with Japan's Nikkei 225 falling 1.47%, China's Shanghai Composite Index falling 0.14%, Hong Kong's Hang Seng Index declining 0.36% and India's BSE Sensex falling 1.59%.
Economics
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42809598/progress-software-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Progress Software Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet

U.S. stocks traded higher midway through trading, with the S&amp;P 500 jumping more than 1% on Monday.
The Dow traded up 0.51% to 42,949.22 while the NASDAQ gained 1.78% to 19,970.13. The S&amp;P 500 also rose, gaining, 1.09% to 6,007.42.
Check This Out: <a href="https://www.benzinga.com/25/01/42810054/this-analyst-with-85-accuracy-rate-sees-around-16-downside-in-tesla-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts">This Analyst With 85% Accuracy Rate Sees Around 16% Downside In Tesla &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Information technology shares jumped by 2.3% on Friday.
In trading on Friday, utilities shares fell by 1.2%.
Top Headline
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) shares shot up 171% to $4.2050. Regional Health announced plans to merge with SunLink in a $10 million preferred stock deal.</li>
<li>Shares of SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>)got a boost, surging 160% to $1.3701 after announcing the publication of a European patent application for binge behavior.</li>
<li>fuboTV Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NASDAQ">FUBO</a>) shares were also up, gaining 153% to $3.6610 after the company announced it entered into a definitive agreement for Disney to combine its Hulu with Fubo to form a virtual MVPD company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) shares dropped 67% to $0.1894 after the company announced the pricing of approximately $20.0 million underwritten public offering.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 39% to $0.1659 after the company reported a $10 million registered direct offering.</li>
<li>Blue Hat Interactive Entertainment Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>) was down, falling 39% to $0.0900 after the company reported the pricing of $4.4 million registered direct offering.</li>
</ul>
Commodities In commodity news, oil traded up 1.1% to $74.75 while gold traded down 0.1% at $2,651.60.
Silver traded up 2.2% to $30.715 on Monday, while copper rose 3.1% to $4.1980.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.54%, Germany's DAX 40 gained 1.05% and France's CAC 40 climbed 1.68%. Spain's IBEX 35 Index rose 0.82%, while London's FTSE 100 fell 0.06%.
Asia Pacific Markets
Asian markets closed lower on Monday, with Japan's Nikkei 225 falling 1.47%, China's Shanghai Composite Index falling 0.14%, Hong Kong's Hang Seng Index declining 0.36% and India's BSE Sensex falling 1.59%.
Economics
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42809598/progress-software-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Progress Software Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

S&P Jumps 1%; Regional Health Properties Shares Spike Higher

BioLineRx shares are trading lower after the company announced a $10 million registered direct offering.

U.S. stocks traded higher this morning, with the Dow Jones index surging more than 200 points on Monday.
Following the market opening Monday, the Dow traded up 0.58% to 42,979.82 while the NASDAQ gained 1.45% to 19,905.93. The S&amp;P 500 also rose, gaining, 1.03% to 6,003.89.
Check This Out: <a href="https://www.benzinga.com/25/01/42810054/this-analyst-with-85-accuracy-rate-sees-around-16-downside-in-tesla-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts">This Analyst With 85% Accuracy Rate Sees Around 16% Downside In Tesla &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Information technology shares jumped by 2% on Monday.
In trading on Monday, utilities shares fell by 0.9%.
Top Headline
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) shares shot up 220% to $4.9164. Regional Health announced plans to merge with SunLink in a $10 million preferred stock deal.</li>
<li>Shares of SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>)got a boost, surging 157% to $1.36 after announcing the publication of a European patent application for binge behavior.</li>
<li>fuboTV Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NASDAQ">FUBO</a>) shares were also up, gaining 133% to $3.36 after the company announced it entered into a definitive agreement for Disney to combine its Hulu with Fubo to form a virtual MVPD company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) shares dropped 69% to $0.1744 after the company announced the pricing of approximately $20.0 million underwritten public offering.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 43% to $0.1543 after the company reported a $10 million registered direct offering.</li>
<li>Blue Hat Interactive Entertainment Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>) was down, falling 42% to $0.0858 after the company reported the pricing of $4.4 million registered direct offering.</li>
</ul>
Commodities In commodity news, oil traded up 1.2% to $74.85 while gold traded down 0.4% at $2,643.60.
Silver traded up 1.7% to $30.565 on Monday, while copper rose 2.8% to $4.1855.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.5%, Germany's DAX 40 gained 1% and France's CAC 40 climbed 1.5%. Spain's IBEX 35 Index rose 0.7%, while London's FTSE 100 rose 0.1%.
Asia Pacific Markets
Asian markets closed lower on Monday, with Japan's Nikkei 225 falling 1.47%, China's Shanghai Composite Index falling 0.14%, Hong Kong's Hang Seng Index declining 0.36% and India's BSE Sensex falling 1.59%.
Economics
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42809598/progress-software-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Progress Software Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

US Stocks Open Higher; Dow Jumps Over 200 Points

BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) (TASE: BLRX)&nbsp;("BioLineRx" or the "Company"), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has entered into definitive agreements for the purchase of an aggregate of 50,000,000&nbsp;of the Company's American Depositary Shares (ADSs) (or ADS equivalents) and accompanying warrants to purchase up to an aggregate of 50,000,000 ADSs, at a purchase price of $0.20 per ADS (or per ADS equivalent) and accompanying warrant in a registered direct offering. The warrants will have an exercise price of $0.20 per share, will be exercisable immediately upon issuance, and will expire five years from the initial exercise date.&nbsp; Each ADS represents fifteen (15) ordinary shares, par value NIS 0.10 per share, of BioLineRx. The closing of the offering is expected to occur on or about January 7, 2025, subject to the satisfaction of customary closing conditions.
H.C. Wainwright &amp; Co. is acting as the exclusive placement agent for the offering.
The aggregate gross proceeds to the Company from the offering are expected to be approximately $10 million, before deducting the placement agent fees and other offering expenses payable by the Company. The Company currently intends to use the net proceeds from the offering for research and development activities, the expansion of the Company's pipeline of potential drug candidates, and working capital and general corporate purposes.

Offerings

BioLineRx Announces $10M Registered Direct Offering Of 50M American Depositary Shares And Accompanying Warrants To Purchase Up To An Aggregate Of 50M ADSs, At A Purchase Price Of $0.20 Per ADS

Shares of Check-Cap Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHEK#NASDAQ">CHEK</a>) rose sharply in today's pre-market trading after the company announced it was granted European Patent Number EP4087488 titled &#8220;RADIATION CAPSULE FOR BOWEL DISEASE IMAGING <a href="https://www.benzinga.com/quote/CHEK">AND LOCALIZE DRUG DELIVERY&#8221;.</a>
Check-Cap shares jumped 52.2% to $1.75 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) gained 151.2% to $0.4760 in pre-market trading after gaining around 7% on Thursday.</li>
<li>BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) gained 91.4% to $0.4891 in pre-market trading after surging 20% on Thursday.</li>
<li>mF International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFI#NASDAQ">MFI</a>) rose 80% to $1.30 in pre-market trading after gaining around 8% on Thursday.</li>
<li>MGO Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) rose 48.5% to $0.8776 in pre-market trading after climbing around 5% on Thursday.</li>
<li>Nine Energy Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NINE#NYSE">NINE</a>) gained 30.9% to $1.61 in pre-market trading following a 10% surge on Thursday.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) gained 27.6% to $0.2630 in pre-market trading after gaining 8% on Thursday.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) gained 27.3% to $2.42 in pre-market trading after dipping 13% on Thursday.</li>
<li>Garrett Motion Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTX#NYSE">GTX</a>) rose 11.3% to $9.92 in pre-market trading.</li>
<li>Meritage Homes Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTH#NYSE">MTH</a>) gained 10.5% to $84.00 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Coeptis Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COEP#NASDAQ">COEP</a>) fell 30.4% to $4.11 in pre-market trading after jumping 7% on Thursday.</li>
<li>T Stamp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) declined 19.8% to $0.5470 in pre-market trading after dipping 23% on Thursday. The company announced it will implement a 1-for-15 reverse stock split.</li>
<li>HWH International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) fell 18.3% to $0.5300 in pre-market trading.</li>
<li>Reservoir Media, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSVR#NASDAQ">RSVR</a>) shares dipped 18% to $7.00 in pre-market trading after falling over 5% on Thursday.</li>
<li>Creative Media &amp; Community Trust Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCT#NASDAQ">CMCT</a>) shares fell 17.9% to $0.1716 in pre-market trading. Creative Media announced approval for a 1-for-10 reverse stock split.</li>
<li>IT Tech Packaging, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITP#NYSE">ITP</a>) fell 14.9% to $0.5700 in today's pre-market trading after jumping more than 11% on Thursday.</li>
<li>Ark Restaurants Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) fell 13.7% to $11.01 in pre-market trading after gaining 16% on Thursday.</li>
<li>Tejon Ranch Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRC#NYSE">TRC</a>) shares fell 11.4% to $14.01 in pre-market trading.</li>
<li>Aura Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AURA#NASDAQ">AURA</a>) dipped 11.1% to $0.75 in pre-market trading.</li>
<li>Lincoln Educational Services Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) shares tumbled 7.7% to $14.10 in pre-market trading after falling over 3% on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42763645/how-to-earn-500-a-month-from-acuity-brands-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Acuity Brands Stock Ahead Of Q1 Earnings</a></li>
</ul>

Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket

HC Wainwright &amp; Co. analyst Joseph Pantginis maintains BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) with a Buy and lowers the price target from $21 to $9.

Price Target

Analyst Ratings

HC Wainwright & Co. Maintains Buy on BioLine Rx, Lowers Price Target to $9

BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) reported quarterly losses of $(0.00) per share which beat the analyst consensus estimate of $(0.05) by 98 percent. The company reported quarterly sales of $4.94 million which missed the analyst consensus estimate of $5.29 million by 6.57 percent.

BioLine Rx Q3 2024 GAAP EPS $(0.00) Beats $(0.05) Estimate, Sales $4.94M Miss $5.29M Estimate

BioLineRx (BLRX) announced that it has entered into definitive agreements for the purchase of an aggregate of 50M of the company's American Deposit...

BioLineRx announces $10M registered direct offering

The latest update is out from Bioline RX Ltd Sponsored ADR ( ($BLRX) ). BioLineRx Ltd. has announced a $10 million registered direct offering invol...

BioLineRx Announces $10 Million Direct Offering to Fuel Growth

BioLineRx announces $10M registered direct offering; shares tumble

Bioline RX Ltd Sponsored ADR ( ($BLRX) ) has issued an update. BiolineRx Ltd., an Israeli company, has announced a registered direct offering invol...

BiolineRx Announces Major Direct Offering to Bolster Operations

BioLineRx (BLRX) announced that its Board of Directors has approved a change in the number of its ordinary shares represented by American Depositar...

BioLineRx changes ratio of ADRs to ordinary shares

The latest update is out from Bioline RX Ltd Sponsored ADR ( ($BLRX) ). On January 17, 2025, BioLineRx Ltd. announced an alteration in the ratio of...

BioLineRx Adjusts ADS Ratio to Maintain Nasdaq Listing

BioLineRx announces change to ratio of ADS to ordinary shares

In a letter to shareholders, CEO Phil Serlin stated, in part, "Proceeds from the Ayrmid and GloriaBio transactions, together with the opportunistic...

BioLineRx says current cash to provide runway through 2H26

Bioline RX Ltd Sponsored ADR ( ($BLRX) ) has shared an announcement. On January 21, 2025, BioLineRx Ltd. issued a letter to shareholders detailing ...

BioLineRx Outlines Strategic Vision and Financial Outlook After Key Licensing Deals

19:50 EST BioLineRx (BLRX) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking finan...

BioLineRx trading halted, news pending

Press Releases

BioLineRx Launches 'Mobilization Matters': A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection

Small Cap

BioLineRx Announces USPTO Allowance of New Composition of Matter Patent on Motixafortide

BioLineRx Announces Oral Presentation on Data from Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease at ASH 2024

BioLineRx to Report Third Quarter 2024 Results on November 25, 2024

BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd.

BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value

Health Care

Silexion Therapeutics Appoints Renowned Cancer Therapeutics Expert Prof. Amnon Peled to Board of Directors

BioLineRx Announces $10 Million Registered Direct Offering

BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares

Comments

BioLine Rx

Noticias

Últimas noticias sobre BioLine Rx (NASDAQ:BLRX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL